investorscraft@gmail.com

Intrinsic ValueWuxi Delinhai Environmental Technology Co., Ltd. (688069.SS)

Previous Close$23.92
Intrinsic Value
Upside potential
Previous Close
$23.92

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Wuxi Delinhai Environmental Technology Co., Ltd. operates as a specialized industrial company within China's critical environmental protection sector, focusing exclusively on cyanobacteria treatment solutions. Its core revenue model is built on the development, sale, integration, and ongoing operation and maintenance of proprietary equipment designed to combat harmful algal blooms in lakes and reservoirs. The company occupies a distinct niche in the pollution and treatment controls industry, providing essential services that address significant water quality and ecological challenges. This specialization positions it as a key technological provider in a market driven by increasing governmental and societal focus on environmental remediation and sustainable water management practices across China.

Revenue Profitability And Efficiency

The company reported revenue of CNY 448.4 million for the period. However, it experienced a net loss of CNY 86.1 million, indicating significant profitability challenges. Despite the loss, it generated positive operating cash flow of CNY 89.2 million, which suggests some underlying operational efficiency in converting sales into cash, though this was insufficient to cover overall expenses and achieve net income.

Earnings Power And Capital Efficiency

The diluted earnings per share was negative CNY 0.78, reflecting the net loss for the period and weak current earnings power. Capital expenditures of CNY 30.8 million indicate ongoing investment in its operational assets. The positive operating cash flow relative to capital spending suggests the core operations can fund some, but not all, of its investment needs.

Balance Sheet And Financial Health

The balance sheet shows a strong liquidity position with cash and equivalents of CNY 266.7 million, which substantially exceeds its total debt of CNY 47.2 million. This low leverage and high cash balance provide a solid buffer for financial health and operational flexibility, mitigating the near-term risks associated with its reported net loss.

Growth Trends And Dividend Policy

Despite the net loss, the company maintained a dividend per share of CNY 0.42, which is a notable commitment to shareholder returns. This policy, juxtaposed with negative earnings, suggests a strategy that may prioritize returning capital or could be supported by its strong cash position, though it is not sustainable long-term without a return to profitability.

Valuation And Market Expectations

With a market capitalization of approximately CNY 2.44 billion, the market is valuing the company at roughly 5.4 times its revenue. A beta of 0.324 indicates the stock has been significantly less volatile than the broader market, potentially reflecting its niche status and specific risk profile disconnected from general economic cycles.

Strategic Advantages And Outlook

The company's strategic advantage lies in its specialized focus on cyanobacteria treatment, a pressing environmental issue in China. Its strong balance sheet provides crucial stability to navigate current profitability challenges. The long-term outlook is tied to continued regulatory emphasis on water quality and the company's ability to leverage its technology to achieve sustainable growth and return to profitability.

Sources

Company Filings (e.g., Annual Report)Public market data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount